FeNO non-suppression identifies corticosteroid-resistant type-2 signaling in severe asthma - Couillard, S; Shrimanker, R; Chaudhuri, R; Mansur, AH; McGarvey, LP; Heaney, LG; Fowler, SJ; Bradding, P; Pavord, ID; Hinks, TSC (Thorax, 2021)